Lansoprazole Pinewood 15mg Gastro-resistant Capsules, Hard
Authorisation PA0281/151/001 · Pinewood Laboratories Limited
- Licence holder
- Pinewood Laboratories Limited (all products →)
- Active substance
- Lansoprazole
- Clinical trials
- 4 clinical trials →
- Dosage form
- Gastro-resistant capsule, hard
- Route of administration
- Oral use
- ATC codes
- A02BC, A02BC03
- First authorised
- 25/11/2013
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Lansoprazole: supply and approvals
16 authorised products on the HPRA list contain Lansoprazole. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 12 years (since 25 November 2013). The HPRA list marks it as marketed in Ireland.
Other medicines with Lansoprazole in Ireland
15 other products on the HPRA list contain Lansoprazole, from 8 licence holders; 12 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Lansoprazole 15 mg gastro-resistant capsules, hard | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Lansoprazole 30 mg gastro-resistant capsules, hard | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Lansoprazole Krka 15 mg Gastro-resistant Capsules, hard | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Lansoprazole Krka 30 mg Gastro-resistant Capsules, hard | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Lansoprazole Pinewood 30mg Gastro-resistant Capsules, Hard | Pinewood Laboratories Limited | National authorisation (PA) | Marketed |
| Lansoprazole Teva Pharma 15 mg gastro-resistant capsules, hard | Teva B.V. | National authorisation (PA) | Marketed |
| Lansoprazole Teva Pharma 30 mg gastro-resistant capsules, hard | Teva B.V. | National authorisation (PA) | Marketed |
| Lanzol 30 mg hard gastro-resistant capsules | Rowex Limited, | National authorisation (PA) | Marketed |
| Zomel 15 mg gastro-resistant capsule, hard | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Zomel 30 mg gastro-resistant capsule, hard | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Zoton FasTab 15 mg Oro-Dispersible Tablets | Pfizer Healthcare Ireland Unlimited Company | National authorisation (PA) | Marketed |
| Zoton FasTab 30 mg oro-dispersible tablets | Pfizer Healthcare Ireland Unlimited Company | National authorisation (PA) | Marketed |
Other substances in ATC group A02BC
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 8 other active substances share the group A02BC with this product:
Omeprazole (17) · Esomeprazole (14) · Pantoprazole sodium sesquihydrate (12) · Pantoprazole (11) · Rabeprazole sodium (6) · Esomeprazole magnesium trihydrate (5) · Omeprazole magnesium (4) · Esomeprazole magnesium dihydrate (2)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Pinewood Laboratories Limited holds 91 products on the HPRA list, with 45 different active substances; 62 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.